Free Trial
OTCMKTS:OMGAQ

Omega Therapeutics (OMGAQ) Stock Price, News & Analysis

Omega Therapeutics logo
$0.07 +0.01 (+7.68%)
As of 11:15 AM Eastern

About Omega Therapeutics Stock (OTCMKTS:OMGAQ)

Key Stats

Today's Range
$0.07
$0.09
50-Day Range
$0.13
$0.13
52-Week Range
$0.01
$2.15
Volume
437,086 shs
Average Volume
4.45 million shs
Market Capitalization
$3.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.50
Consensus Rating
Moderate Buy

Company Overview

Omega Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

OMGA MarketRank™: 

Omega Therapeutics scored higher than 41% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Omega Therapeutics has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Omega Therapeutics has received no research coverage in the past 90 days.

  • Read more about Omega Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Omega Therapeutics are expected to grow in the coming year, from ($1.25) to ($0.99) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Omega Therapeutics is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Omega Therapeutics is -0.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Omega Therapeutics has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for OMGA.
  • Dividend Yield

    Omega Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Omega Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for OMGA.
  • Search Interest

    Only 1 people have searched for OMGA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Omega Therapeutics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Omega Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.50% of the stock of Omega Therapeutics is held by insiders.

  • Percentage Held by Institutions

    97.47% of the stock of Omega Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Omega Therapeutics' insider trading history.
Receive OMGAQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

OMGAQ Stock News Headlines

Omega Therapeutics Inc (OMGAQ)
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

OMGA Stock Analysis - Frequently Asked Questions

Omega Therapeutics' stock was trading at $0.7456 on January 1st, 2025. Since then, OMGA shares have decreased by 83.2% and is now trading at $0.1250.

Omega Therapeutics, Inc. (NASDAQ:OMGA) released its quarterly earnings data on Tuesday, August, 6th. The company reported ($0.30) earnings per share for the quarter, beating analysts' consensus estimates of ($0.36) by $0.06. The company earned $2.13 million during the quarter, compared to analysts' expectations of $1.25 million. Omega Therapeutics had a negative trailing twelve-month return on equity of 213.13% and a negative net margin of 902.93%.

Omega Therapeutics (OMGA) raised $126 million in an initial public offering on Friday, July 30th 2021. The company issued 7,400,000 shares at $16.00-$18.00 per share.

Shares of OMGA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Omega Therapeutics investors own include Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), American Water Works (AWK), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/06/2024
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:OMGA
CIK
1850838
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$4.00
Potential Upside/Downside
+6,700.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.33)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$97.43 million
Net Margins
-902.93%
Pretax Margin
-902.93%
Return on Equity
-213.13%
Return on Assets
-41.24%

Debt

Debt-to-Equity Ratio
1.00
Current Ratio
1.61
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$8.10 million
Price / Sales
0.85
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.05 per share
Price / Book
0.12

Miscellaneous

Outstanding Shares
55,366,000
Free Float
50,660,000
Market Cap
$6.92 million
Optionable
Optionable
Beta
1.65
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:OMGAQ) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners